| [1] |
Gencosmanoglu R, Unalan P, Kir G, et al. Breast cancer and immune thrombocytopenic purpura: is there any association between these 2 distinct diseases?[J]. Breast Care, 2007, 2: 317-320.
|
| [2] |
Cockrell DC, Kasthuri RS, Altun E, et al. Secondary immune thrombocytopenia in metastatic renal cell carcinoma: A case report and discussion of the literature[J]. Case Rep Oncol, 2020, 13(3): 1349-1356.
|
| [3] |
Xie X, Wang N, Xiang J, et al. Renal cell carcinoma associated with idiopathic thrombocytopenic purpura[J]. Int J Immunopathol Pharmacol, 2020, 34: 2058738420931619.
|
| [4] |
黄梦贞, 王诗轩, 李菲. 慢性淋巴细胞白血病相关免疫性血小板减少的病理机制及治疗进展[J]. 中国实验血液学杂志, 2021, 29(5): 1671-1675.
|
| [5] |
O'Connor-Byrne N, Quinn J, Glavey SV, et al. Venetoclax for chronic lymphocytic leukemia associated immune thrombocytopenia following recovery from progressive multifocal leukoencephalopathy[J]. Leuk Res, 2020, 95: 106390.
|
| [6] |
Wahid FS, Fun LC, Keng CS, et al. Breast carcinoma presenting as immune thrombocytopenic purpura[J]. Int J Hematol, 2001, 73(3): 399-400.
|
| [7] |
Peffault de Latour R, Des Guetz G, Laurence V, et al. Breast cancer associated with idiopathic thrombocytopenic purpura: A single center series of 10 cases[J]. Am J Clin Oncol, 2004, 27(4): 333-336.
|
| [8] |
Niu J, Goldin T, Markman M, et al. Metastatic breast cancer with extensive osseous metastasis presenting with symptomatic immune thrombocytopenic purpura and anemia: A case report and review of the literature[J]. Case Rep Oncol, 2015, 8(2): 256-263.
|
| [9] |
Hügli S, Hügli A, Simonetta F, et al. A rare case of immune thrombocytopenia secondary to breast cancer[J]. Clin Case Rep, 2019, 7(1): 170-174.
|
| [10] |
Xiao L, Hu X, Wang S, et al. A case report of local recurrence developing 24 years after mastectomy for breast cancer recurrence from breast cancer after 24 years[J]. Medicine (Baltimore), 2016, 95(22): e3807.
|
| [11] |
Samimi MA, Mirkheshti N, Heidarpour M, et al. Idiopathic thrombocytopenic purpura in women with breast cancer[J]. J Res Med Sci, 2010, 15(6): 359-363.
|
| [12] |
Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment[J]. Am J Hematol, 2021, 96(2): 188-198.
|
| [13] |
中华医学会血液学分会血栓与止血学组. 成人原发免疫性血小板减少症诊断与治疗中国指南（2020年版）[J]. 中华血液学杂志, 2020, 41(8): 617-623.
|
| [14] |
Wang J, Zhou P, Han Y, et al. Platelet transfusion for cancer secondary thrombocytopenia: platelet and cancer cell interaction[J]. Transl Oncol, 2021, 14(4): 101022.
|
| [15] |
Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia[J]. Blood Adv, 2019, 3(23): 3829-3866.
|